CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Kymera Therapeutics, Inc. - KYMR CFD

36.85
4.16%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.18
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.030779%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.013666%
隔夜费时间 22:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 38.69
开盘价* 37.76
1 年变化* -11.19%
日范围* 37.08 - 38.34
52 周范围 13.15-46.22
平均交易量(10 天) 566.19K
平均交易量(3 个月) 15.57M
市值 2.01B
市盈率 -100.00K
流通股 54.86M
收入 45.96M
EPS -2.94
股息(收益率 %) N/A
贝塔 -100.00K
下一个财报发布日期 Feb 23, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Feb 2, 2023 38.69 1.64 4.43% 37.05 39.72 35.90
Feb 1, 2023 36.58 0.61 1.70% 35.97 37.57 35.49
Jan 31, 2023 37.34 1.96 5.54% 35.38 37.91 35.33
Jan 30, 2023 36.32 0.35 0.97% 35.97 36.49 35.39
Jan 27, 2023 36.81 2.20 6.36% 34.61 37.51 34.61
Jan 26, 2023 35.42 -0.54 -1.50% 35.96 37.38 34.85
Jan 25, 2023 36.65 0.96 2.69% 35.69 37.10 35.54
Jan 24, 2023 37.22 2.65 7.67% 34.57 37.26 34.57
Jan 23, 2023 35.51 0.65 1.86% 34.86 35.54 33.96
Jan 20, 2023 34.92 1.51 4.52% 33.41 35.05 32.97
Jan 19, 2023 33.13 -0.34 -1.02% 33.47 34.06 31.52
Jan 18, 2023 34.53 0.80 2.37% 33.73 35.48 33.73
Jan 17, 2023 34.61 -0.16 -0.46% 34.77 34.87 33.61
Jan 13, 2023 34.48 2.39 7.45% 32.09 34.93 32.08
Jan 12, 2023 33.51 4.42 15.19% 29.09 33.61 29.09
Jan 11, 2023 29.83 1.52 5.37% 28.31 29.95 28.05
Jan 10, 2023 29.45 2.80 10.51% 26.65 29.79 26.64
Jan 9, 2023 27.00 -0.27 -0.99% 27.27 27.62 25.97
Jan 6, 2023 27.27 0.84 3.18% 26.43 27.70 25.65
Jan 5, 2023 26.15 0.58 2.27% 25.57 26.52 24.46

Kymera Therapeutics, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • 年度
  • 每季度
2018 2019 2020 2021
总收入 0 2.934 34.034 72.832
收入 0 2.934 34.034 72.832
总营业费用 21.451 45.139 80.338 173.362
销售/一般/行政费用,总计 3.772 7.981 18.233 36.345
研究与开发 17.679 37.158 62.105 137.017
营业收入 -21.451 -42.205 -46.304 -100.53
利息收入(费用),非经营净值 -0.016 0.959 0.711 0.313
税前净收入 -21.467 -41.246 -45.593 -100.217
税后净收入 -21.467 -41.246 -45.593 -100.217
未计算非常项目前的净收益 -21.467 -41.246 -45.593 -100.217
净收入 -21.467 -41.246 -45.593 -100.217
普通股股东可获收益 (不含非经常性项目) -21.467 -41.246 -54.643 -100.217
普通股股东可获收益 (含非經常性項目) -21.467 -41.246 -54.643 -100.217
摊薄净收入 -21.467 -41.246 -54.643 -100.217
摊薄后加权平均股 43.1386 43.1386 44.4822 47.989
扣除特别项目的每股摊薄盈利 -0.49763 -0.95613 -1.22842 -2.08833
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -0.49763 -0.95613 -1.22842 -2.08833
Total Adjustments to Net Income -9.05 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
总收入 18.702 18.519 20.336 15.275 9.622
收入 18.702 18.519 20.336 15.275 9.622
总营业费用 31.871 43.249 48.973 49.269 46.555
销售/一般/行政费用,总计 5.909 8.029 10.667 11.74 10.611
研究与开发 25.962 35.22 38.306 37.529 35.944
营业收入 -13.169 -24.73 -28.637 -33.994 -36.933
利息收入(费用),非经营净值 0.094 0.07 0.055 0.094 0.249
税前净收入 -13.075 -24.66 -28.582 -33.9 -36.684
税后净收入 -13.075 -24.66 -28.582 -33.9 -36.684
未计算非常项目前的净收益 -13.075 -24.66 -28.582 -33.9 -36.684
净收入 -13.075 -24.66 -28.582 -33.9 -36.684
Total Adjustments to Net Income 0 0 0 0
普通股股东可获收益 (不含非经常性项目) -13.075 -24.66 -28.582 -33.9 -36.684
普通股股东可获收益 (含非經常性項目) -13.075 -24.66 -28.582 -33.9 -36.684
摊薄净收入 -13.075 -24.66 -28.582 -33.9 -36.684
摊薄后加权平均股 44.6496 45.0942 50.7149 51.4312 51.6511
扣除特别项目的每股摊薄盈利 -0.29284 -0.54685 -0.56358 -0.65913 -0.71023
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.29284 -0.54685 -0.56358 -0.65913 -0.71023
  • 年度
  • 每季度
2018 2019 2020 2021
流动资产总额 41.79 92.845 302.339 451.273
现金和短期投资 41.26 91.957 296.202 442.418
现金等价物 41.26 76.015 31.004 47.976
短期投资 0 15.942 265.198 394.442
应收账款总额,净额 0.148 0 1.433 0.135
Prepaid Expenses 0.382 0.888 4.704 8.72
Total Assets 44.231 116.702 487.175 605.905
Property/Plant/Equipment, Total - Net 2.242 22.083 20.686 21.307
Property/Plant/Equipment, Total - Gross 2.466 23.132 22.833 25.223
Accumulated Depreciation, Total -0.224 -1.049 -2.147 -3.916
Other Long Term Assets, Total 0.199 1.774 1.619 8.138
Total Current Liabilities 4.687 34.57 110.617 92.542
Accounts Payable 2.056 3.276 4.368 4.005
Accrued Expenses 2.225 7.175 12.896 25.08
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.302 0.681 0.689 1.138
Other Current Liabilities, Total 0.104 23.438 92.664 62.319
Total Liabilities 5.238 82.028 203.287 146.267
Total Long Term Debt 0.393 1.165 0.604 1.14
Capital Lease Obligations 0.393 1.165 0.604 1.14
Other Liabilities, Total 0.158 46.293 92.066 52.585
Total Equity 38.993 34.674 283.888 459.638
Redeemable Preferred Stock 73.429 109.08
Common Stock 0 0 0.004 0.005
Additional Paid-In Capital 0.774 2.044 412.777 689.275
Retained Earnings (Accumulated Deficit) -35.21 -76.456 -128.765 -228.982
Other Equity, Total 0 0.006 -0.128 -0.66
Total Liabilities & Shareholders’ Equity 44.231 116.702 487.175 605.905
Total Common Shares Outstanding 43.1386 43.1386 44.4822 51.5362
Accounts Receivable - Trade, Net 0.856 0.135
Long Term Investments 162.531 125.187
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
流动资产总额 340.791 364.806 543.731 451.273 431.382
现金和短期投资 333.537 359.107 536.386 442.418 420.812
现金等价物 53.098 84.903 156.819 47.976 33.733
短期投资 280.439 274.204 379.567 394.442 387.079
应收账款总额,净额 1.734 0.904 1.573 0.135 1.263
Accounts Receivable - Trade, Net 0.878 0.904 1.573 0.135 1.263
Prepaid Expenses 5.52 4.795 5.772 8.72 9.307
Total Assets 464.552 434.386 642.453 605.905 563.06
Property/Plant/Equipment, Total - Net 20.502 21.766 21.724 21.307 21.066
Property/Plant/Equipment, Total - Gross 23.127 24.942 24.951 25.223 25.668
Accumulated Depreciation, Total -2.625 -3.176 -3.227 -3.916 -4.602
Long Term Investments 101.639 45.305 74.692 125.187 102.478
Other Long Term Assets, Total 1.62 2.509 2.306 8.138 8.134
Total Current Liabilities 110.137 108.685 94.493 92.542 88.339
Accounts Payable 8.348 8.177 5.033 4.005 2.567
Accrued Expenses 12.962 16.838 21.105 25.08 22.913
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.64 1.038 1.189 1.138 1.087
Other Current Liabilities, Total 88.187 82.632 67.166 62.319 61.772
Total Liabilities 189.305 176.282 159.318 146.267 134.34
Total Long Term Debt 0.498 1.145 1.347 1.14 0.927
Capital Lease Obligations 0.498 1.145 1.347 1.14 0.927
Other Liabilities, Total 78.67 66.452 63.478 52.585 45.074
Total Equity 275.247 258.104 483.135 459.638 428.72
Common Stock 0.004 0.005 0.005 0.005 0.005
Additional Paid-In Capital 417.096 424.599 678.358 689.275 697.597
Retained Earnings (Accumulated Deficit) -141.84 -166.5 -195.082 -228.982 -265.666
Other Equity, Total -0.013 0 -0.146 -0.66 -3.216
Total Liabilities & Shareholders’ Equity 464.552 434.386 642.453 605.905 563.06
Total Common Shares Outstanding 44.8794 45.3277 51.2565 51.5362 51.6927
  • 年度
  • 每季度
2018 2019 2020 2021
净收入/起跑线 -21.467 -41.246 -45.593 -100.217
经营活动产生的现金 -17.863 17.905 88.13 -128.946
经营活动产生的现金 0.205 0.825 1.763 2.397
非现金物品 1.091 1.639 7.093 30.797
已付现金利息 0.015 0.046 0.115 0.158
营运资金的变化 2.308 56.687 124.867 -61.923
投资活动产生的现金 -1.356 -16.486 -422.588 -99.835
资本支出 -1.356 -0.532 -9.096 -1.597
其他投资现金流量项目,总计 0 -15.954 -413.492 -98.238
融资活动产生的现金 52.932 34.911 289.262 250.28
股票的发行(报废),净额 53.227 35.282 276.289 249.18
债务的发行(退还),净额 -0.295 -0.371 -0.554 -0.849
现金净变化 33.713 36.33 -45.196 21.499
融资现金流项目 13.527 1.949
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -13.075 -37.735 -66.317 -100.217 -36.684
Cash From Operating Activities -22.823 -53.334 -90.594 -128.946 -40.295
Cash From Operating Activities 0.485 1.037 1.708 2.397 0.687
Non-Cash Items 4.451 11.409 20.483 30.797 9.048
Cash Interest Paid 0.024 0.054 0.106 0.158 0.046
Changes in Working Capital -14.684 -28.045 -46.468 -61.923 -13.346
Cash From Investing Activities 44.323 105.046 -31.816 -99.835 25.863
Capital Expenditures -0.164 -0.79 -1.096 -1.597 -0.482
Other Investing Cash Flow Items, Total 44.487 105.836 -30.72 -98.238 26.345
Cash From Financing Activities 0.595 2.187 248.226 250.28 0.185
Financing Cash Flow Items -0.397 -0.397 1.95 1.949 0
Issuance (Retirement) of Stock, Net 1.147 2.925 246.969 249.18 0.449
Issuance (Retirement) of Debt, Net -0.155 -0.341 -0.693 -0.849 -0.264
Net Change in Cash 22.095 53.899 125.816 21.499 -14.247
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Atlas Venture Venture Capital 10.7654 5906385 -126474 2023-01-12 LOW
BVF Partners L.P. Hedge Fund 8.6278 4733611 41007 2023-01-12 LOW
T. Rowe Price Associates, Inc. Investment Advisor 7.4299 4076383 -1148303 2022-09-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 6.216 3410386 -1624554 2022-09-30 LOW
Vertex Pharmaceuticals Inc Corporation 5.8344 3201049 49928 2022-03-31
Baker Bros. Advisors LP Hedge Fund 5.249 2879825 0 2022-09-30 LOW
Redmile Group, LLC Investment Advisor/Hedge Fund 5.2431 2876637 269507 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.2046 2855478 -14485 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.8946 2685404 -829034 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.8611 2667006 147376 2022-09-30 LOW
Avoro Capital Advisors LLC Investment Advisor/Hedge Fund 3.9538 2169230 909230 2022-09-30 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 3.639 1996529 634040 2022-09-30 HIGH
Invus Public Equities Advisors, LLC Investment Advisor 2.734 1500000 500000 2022-09-30 LOW
Wasatch Global Investors Inc Investment Advisor/Hedge Fund 1.933 1060561 489917 2022-09-30 LOW
Rock Springs Capital Management LP Hedge Fund 1.9079 1046743 270864 2022-09-30 LOW
EcoR1 Capital, LLC Hedge Fund 1.451 796093 796093 2022-09-30 MED
Mellon Investments Corporation Investment Advisor/Hedge Fund 1.3139 720875 -28167 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.2781 701222 25375 2022-09-30 LOW
Bessemer Venture Partners Venture Capital 1.1226 615895 0 2022-09-30 LOW
Mainolfi (Nello) Individual Investor 1.0424 571931 10000 2022-12-08 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group
+485000+

交易者

65000+

每月活跃客户

$48000000+

每月投资额

$28000000+

每月提取金额

交易計算器

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

貿易佣金
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
杠杆
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Kymera Therapeutics, Inc. Company profile

关于 Kymera Therapeutics Inc.

Kymera Therapeutics, Inc.是一家生物制药公司。 公司专注于发现和开发小分子疗法,通过利用人体自身的天然蛋白质降解系统选择性地降解致病蛋白质。 其靶向蛋白降解(TPD)平台Pegasus,使其能够发现对整个身体的致病蛋白具有活性的选择性小分子蛋白降解剂。 公司的Pegasus平台包括E3配体酶全身图谱、E3配体酶粘合剂工具箱、三元复合体模型、定量系统药理学模型和化学。 其临床阶段的项目包括IRAK4、IRAKIMiD和STAT3,它们分别针对白细胞介素-1受体/棒状受体(IL-1R/TLR)和贾努斯激酶/信号转导者和转录激活者(JAK/STAT)中的目标。 其项目重点是治疗一系列免疫炎症性疾病、血液学恶性肿瘤和实体瘤。

Industry: Biotechnology & Medical Research (NEC)

200 Arsenal Yards Blvd., Suite 230
2Nd Floor
WATERTOWN
MASSACHUSETTS 02472
US

收入报表

  • Annual
  • Quarterly

人们也观看

Natural Gas

2.44 Price
-1.700% 1D Chg, %
多头隔夜费 -0.1145%
空头隔夜费 0.0801%
隔夜费时间 22:00 (UTC)
价差 0.005

XRP/USD

0.41 Price
+0.120% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 0.00345

Oil - Crude

73.47 Price
-3.420% 1D Chg, %
多头隔夜费 -0.0216%
空头隔夜费 0.0063%
隔夜费时间 22:00 (UTC)
价差 0.03

BTC/USD

23,400.20 Price
+0.000% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 60.00

还在找一位您可以信任的经纪商吗?

加入成为全球485,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易